$1.64
-0.11-6.29%
At Close: -
$1.60
-0.04-2.44%
After Hours: 6:29 PM EDT
15 minutes delayed
Comments
Loading...
XORTX Therapeutics (NASDAQ:XRTX) Stock, Earnings Estimates, EPS, And Revenue
XORTX Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 14
EPS
$0.060
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of XORTX Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
XORTX Therapeutics (XRTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $1.36 | $-0.44 | 409.1 % |
| Sep 2023 | 2023-11-16 | $-0.67 | $-0.19 | -252.6 % |
| Mar 2023 | 2023-04-03 | $-1.35 | $-1.44 | 6.25 % |
XORTX Therapeutics (XRTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?
XORTX Therapeutics (XRTX) is scheduled to report earnings on November 14, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for XORTX Therapeutics (NASDAQ:XRTX)?
The Actual EPS was $0.06, which beat the estimate of $0.00.
What were XORTX Therapeutics’s (NASDAQ:XRTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.